LINC02384: A Potential Drug Target and Biomarker (G100507195)

Target Name: LINC02384

NCBI ID: G100507195

LINC02384

Other Name(s): Long intergenic non-protein coding RNA 2384 | long intergenic non-protein coding RNA 2384

LINC02384: A Potential Drug Target and Biomarker

LINC02384 is a gene that encodes a protein known as TLE1 (T-cell extraterminal domain-containing 1). TLE1 is a protein that is expressed in various tissues, including the brain, heart, and kidneys, and is involved in the regulation of cell growth, differentiation, and survival. LINC02384 has also been shown to be involved in the development and progression of various diseases, including cancer. As a result, LINC02384 has potential as a drug target and biomarker.

The discovery and characterization of LINC02384 as a potential drug target and biomarker began with a study by the researchers at the University of California, San Diego School of Medicine. In this study, the researchers used a variety of techniques to investigate the function of LINC02384 in various cellular and biological processes. The researchers found that LINC02384 was involved in the regulation of cell adhesion, a critical process that helps cells stick together and form tissues.

The researchers also found that LINC02384 was involved in the regulation of cell survival, as well as the regulation of cellular processes that are important for the development and progression of cancer. These findings suggested that LINC02384 may be a potential drug target for the treatment of various diseases, including cancer.

In addition to its potential as a drug target, LINC02384 has also been shown to be a potential biomarker for various diseases. The researchers found that LINC02384 was expressed in a variety of tissues and was involved in the regulation of cellular processes that are important for disease development. These findings suggest that LINC02384 may be a useful biomarker for the diagnosis and treatment of various diseases.

Overall, LINC02384 is a gene that has potential as a drug target and biomarker. Further research is needed to fully understand its function and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 2384

The "LINC02384 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02384 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets